JP Morgan Chase
KRRO icon

JP Morgan Chase’s Korro Bio KRRO Stock Holding History

JP Morgan Chase’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$704K Buy
68,500
+65,662
+2,314% +$723K ﹤0.01% 4800
2025
Q4 		$22.7K Sell
2,838
-196,411
-99% -$4.59M ﹤0.01% 6472
2025
Q3 		$9.54M Buy
199,249
+196,079
+6,185% +$4.35M ﹤0.01% 2757
2025
Q2 		$39.6K Buy
3,170
+101
+3% +$1.45K ﹤0.01% 5999
2025
Q1 		$53.4K Buy
3,069
+215
+8% +$6.38K ﹤0.01% 5858
2024
Q4 		$109K Sell
2,854
-9,537
-77% -$490K ﹤0.01% 5726
2024
Q3 		$414K Buy
12,391
+9,782
+375% +$412K ﹤0.01% 5024
2024
Q2 		$88.4K Sell
2,609
-10,554
-80% -$583K ﹤0.01% 5589
2024
Q1 		$1.18M Buy
13,163
+13,145
+73,028% +$717K ﹤0.01% 4221
2023
Q4 		$862 Buy
18
+6
+50% +$198 ﹤0.01% 6855
2023
Q3 		$223 Buy
12
+1
+9% +$25 ﹤0.01% 6832
2023
Q2 		$196 Hold
11
– – ﹤0.01% 6635
2023
Q1 		$0 Hold
11
– – ﹤0.01% 6990
2022
Q4 		$2K Sell
11
-29
-73% -$2.98K ﹤0.01% 6317
2022
Q3 		$4K Buy
40
+14
+54% +$1.42K ﹤0.01% 6145
2022
Q2 		$2K Sell
26
-20,999
-100% -$1.42M ﹤0.01% 6286
2022
Q1 		$2.23M Sell
21,025
-2,325
-10% -$444K ﹤0.01% 3660
2021
Q4 		$5.99M Sell
23,350
-2,313
-9% -$703K ﹤0.01% 2904
2021
Q3 		$9.06M Sell
25,663
-3,221
-11% -$1.27M ﹤0.01% 2469
2021
Q2 		$14.4M Buy
28,884
+28,556
+8,706% +$13.9M ﹤0.01% 2110
2021
Q1 		$155K Buy
328
+101
+44% +$196K ﹤0.01% 5246
2020
Q4 		$401K Sell
227
-123
-35% -$162K ﹤0.01% 4497
2020
Q3 		$346K Buy
350
+43
+14% +$46.2K ﹤0.01% 4138
2020
Q2 		$356K Buy
307
+115
+60% +$104K ﹤0.01% 3997
2020
Q1 		$171K Buy
192
+154
+405% +$166K ﹤0.01% 4329
2019
Q4 		$33K Buy
+38
New +$29.6K ﹤0.01% 5235

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

JP Morgan Chase's KRRO Position: Q1 2026 in Review

JP Morgan Chase increased its Korro Bio (KRRO) stake by 2,314% in Q1 2026, buying an estimated $723K and bringing the position to 68,500 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #4800.

JP Morgan Chase first reported a position in KRRO in Q4 2019 and has held it in 26 quarters since. The position peaked at $14.4M in Q2 2021. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • JP Morgan Chase held 68,500 shares of Korro Bio worth $704K as of Q1 2026.
  • JP Morgan Chase bought 65,662 Korro Bio shares in Q1 2026, an estimated $723K.
  • Korro Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4800 holding.
  • JP Morgan Chase first reported a position in Korro Bio in Q4 2019 and has held it in 26 quarters since.
  • JP Morgan Chase's Korro Bio position peaked at $14.4M in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.